Wednesday, October 22, 2025

2:00 PM - 2:45 PM

---

Overview

2:25 PM - 2:45 PM

---

Details

As the global geopolitical situation is getting increasingly complex, it is crucial for Biotech and MedTech companies to explore strategies to diversify their risks and global operations. In this context, the Asia-Pacific region, particularly the markets of Asia and China, presents a significant opportunity for Australian companies seeking expansion. Hong Kong, in particular, stands out as an attractive destination for Biotech development. The city serves as a gateway to the vast markets of mainland China and the broader Asian region, offering unique advantages for companies in this sector. In addition, the Hong Kong government is deeply committed to fostering the growth of the Biotech and MedTech sectors, implementing policies and initiatives designed to attract and support innovative companies. This includes funding programs, tax incentives, access to world-class research facilities, and strong frameworks for intellectual property protection as well as trading. InvestHK, a Hong Kong Government agency, can offer tailored support to help businesses navigate the local landscape, including connections with key stakeholders, industry networks, and potential partners. By establishing a presence in Hong Kong, companies can benefit from a strategic location, a skilled workforce, and a robust infrastructure, all of which are essential for driving innovation and growth in the biotech field. Overall, Hong Kong's supportive ecosystem, combined with its access to the expansive Asian market, makes it an ideal hub for Biotech and MedTech companies looking to thrive in a dynamic and evolving global environment.

---

Speaker